Reuters Market Eye - Shares in mid-sized drug makers extend a recent rally as dealers cite evidence of good buying by foreign institutional investors (FIIs).
"A weaker rupee and an increasingly diversified revenue base are attracting FIIs," said a dealer with a domestic brokerage.
Shares of Aurobindo Pharma Ltd gain 1.8 percent, bringing the gains over the past eight sessions including Thursday to 37 percent.
Wockhardt Ltd is up 2.2 percent, heading for its sixth daily gain in the past seven sessions for a total gain of 28 percent so far during that period.
(Reporting by Indulal PM)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories
Over 30 subscriber-only stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app